Back to top

Analyst Blog

Leading drugstore chain operator Rite Aid Corp. (RAD - Analyst Report) posted higher net loss of $197.0 million in the second-quarter of fiscal 2011, compared to a loss of $116.0 million in the year-ago period. The quarterly loss per share of 23 cents was much greater than the Zacks Consensus Estimate for a loss of 11 cents. The loss incurred was primarily due to a $44 million or 5 cents charge on debt modification related to the company’s recent refinancing and lower sales.

Quarterly Details


Rite Aid’s revenues declined 2.5% year over year to $6.2 billion from $6.3 billion, primarily due to a 1.5% decline in same-store sales, coupled with the net closure of 65 stores over the past year. During the quarter, the company closed 20 stores, relocated 5 and remodeled 1.

Pharmacy same-store sales decreased 1.8%, hurt by the introduction of new generic drugs, while prescriptions filled at comparable stores decreased 2.1% from the year-ago quarter. Front-end same-stores sales declined 0.9% year over year. Other than prescription drugs, Rite Aid sells a wide assortment of other merchandise, which it terms as "front end" products, including over-the-counter medications, health and beauty aids, personal care items and cosmetics.

Rite Aid’s gross profit fell 2.9% year over year to $1.6 billion, while gross margin contracted 11 basis points (bps) to 26.6%. Selling, general and administrative expenses (SG&A) declined 1.2% year over year to $1.6 billion, mainly due to management’s cost containment initiatives.

The company also recorded an 8.3% reduction in lease termination and impairment charges to $26.3 million, primarily due to fewer store closures in the reported quarter. Despite cost saving measures, Rite Aid reported operating loss (gross profit less SG&A and lease termination and impairment) of $194.1 million, compared to an operating loss of $112.0 million in the prior year quarter.

Balance Sheet and Cash Flow

At the end of the quarter, Rite Aid had cash and cash equivalents of $132.4 million and long-term debt of $6.0 billion, compared to a cash balance of $103.6 million and long-term debt of $6.2 billion in the year-ago period. During the quarter, the company deployed $158 million towards debt repayment and $82.7 million towards capital expenditure.

Guidance and Zacks Consensus

Looking ahead, Rite Aid revised its fiscal 2011 revenue guidance to $25.0 billion to $25.4 billion from $25.2 billion to $25.6 billion. Net loss is now expected to be in the range of $400 million to $590 million or -46 cents to -67 cents. Earlier guidance was $355 million to $570 million, or -41 cents to -65 cents per share.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
UNITED THER… UTHR 117.83 +28.51%
TRIQUINT SE… TQNT 20.67 +6.52%
RF MICRO DE… RFMD 12.47 +6.04%
VASCO DATA… VDSI 14.77 +4.68%
BANCO DO BR… BDORY 15.53 +3.95%